|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.59 USD | -0.87% |
|
-7.40% | -8.14% |
| 14/01 | BioMarin Pharmaceuticals Aims for Sustained Growth in 2026, Wedbush Says | MT |
| 13/01 | BioMarin Pharmaceutical Reports Preliminary 2025 Revenue, Details Asset Write-Down | MT |
EPS & Dividend: BioMarin Pharmaceutical Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 4.53 | -0.35 | 0.75 | 0.87 | 2.21 | 2.649 | 4.024 | 4.616 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 87.69 | 88.35 | 103.49 | 96.42 | 65.73 | 54.59 | 54.59 | 54.59 |
| Nbr of stocks (in thousands) | 1,81,530 | 1,83,593 | 1,85,849 | 1,88,368 | 1,90,583 | 1,92,114 | 1,92,114 | - |
| Announcement Date | 25/02/21 | 23/02/22 | 27/02/23 | 22/02/24 | 19/02/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: BioMarin Pharmaceutical Inc.
| 25/02/2026 | Q4 2025 Earnings Release (Projected) |
| 29/04/2026 | Q1 2026 Earnings Release (Projected) |
| 04/08/2026 | Q2 2026 Earnings Release (Projected) |
| 03/11/2026 | Q3 2026 Earnings Release (Projected) |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | 20.6x | 1.7x | 2.9x | |
| 0.5% | 0.53% | 17.95x | 2.36x | 4.83x | |
| -.--% | -.--% | 58.66x | 7.89x | 15.52x | |
| 0.53% | 0.55% | 44.56x | 4.73x | 7.05x | |
| 2.62% | 2.84% | 22.43x | 2.8x | 4.08x | |
| -.--% | -.--% | 15.84x | 1.31x | 2.63x | |
| -.--% | -.--% | 17.13x | 3.62x | 3.39x | |
| -.--% | 0.02% | 81.94x | 7.95x | 9.81x | |
| - | - | 381.84x | 69.03x | 115.87x | |
| -.--% | -.--% | -5.19x | 1.92x | 5.92x | |
| Average | 0.41% | 0.44% | 65.58x | 10.33x | 17.20x | |
| Weighted average by Cap. | 0.63% | 0.68% | 51.09x | 7.48x | 12.68x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition